Log in Book a Demo

US Pharma & Biotech Oncology - PPC Market Share Analysis May 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Oncology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Oncology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
keytruda.com 9.4
cancer.org 5.56
breyanzi.com 4.8
mayoclinic.org 3.31
letschatcart.com 3.19
kisqali.com 2.8
themmrf.org 2.17
lilly.com 1.87
nubeqa-us.com 1.57
enhertu.com 1.54
others 63.79

Copyright © Adthena. All rights reserved.

In the oncology PPC landscape, ‘keytruda.com’ leads with 9.4% click share, followed by ‘cancer.org’ at 5.56%. ‘Others’ dominate with 63.79%, highlighting diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Oncology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date kisqali.com keytruda.com kisqali-hcp.com opdivo.com lilly.com breyanzi.com nubeqa-us.com brukinsa.com trodelvy.com cancer.org
2025/04/01 0.2% 0.01% 0% 0% 1.04% 5.7% 10.19% 2.22% 5.64% 3.1%
2025/04/02 0.29% 0.02% 0% 0% 0.58% 5.56% 10.49% 2.56% 6.56% 3.48%
2025/04/03 0.15% 0.01% 0% 0% 0.65% 6.14% 7.89% 1.85% 4.09% 2.88%
2025/04/04 6.1% 8.67% 2.41% 1.42% 2.54% 3.66% 6.19% 2.06% 2.5% 1.59%
2025/04/05 6.8% 7.83% 2.85% 2.1% 3.16% 3.47% 4.02% 2.63% 2.76% 1.81%
2025/04/06 4.62% 9.68% 2.31% 1.22% 3.57% 4.14% 3.22% 2.67% 3.03% 2%
2025/04/07 7.86% 9.18% 3.04% 1.68% 3.6% 3.59% 3.71% 2.51% 3.59% 1.85%
2025/04/08 6.83% 6.46% 3.81% 1.56% 2.67% 4.63% 3.18% 2.44% 3.68% 1.55%
2025/04/09 7.26% 8.62% 2.56% 1.93% 8.45% 2.92% 4.49% 2.18% 3.39% 1.24%
2025/04/10 9.35% 7.08% 3.97% 2.02% 2.18% 4.43% 4.47% 1.77% 3.8% 0.78%
2025/04/11 4.34% 9.05% 2.86% 2.48% 4.26% 3.72% 1.08% 2.37% 3.72% 1.66%
2025/04/12 7.28% 9% 2.85% 1.84% 2.67% 4.52% 2.93% 2.29% 3.52% 2.44%
2025/04/13 9.33% 8.54% 3.54% 0.97% 2.79% 3.7% 2.96% 2.17% 2.8% 3.02%
2025/04/14 6.92% 7.62% 3.05% 1.08% 3.42% 4.01% 2.54% 1.32% 3.71% 5.08%
2025/04/15 5.85% 7.23% 2.82% 2.11% 5.82% 5.45% 3.31% 1.89% 3.94% 3.12%
2025/04/16 3.78% 8.4% 1.68% 1.76% 2.08% 5.55% 3% 1.62% 3.83% 2.11%
2025/04/17 5.92% 8.68% 2.07% 3.12% 3.05% 4.05% 2.75% 1.08% 2.14% 1.2%
2025/04/18 12.64% 9.37% 4.65% 2.95% 4.97% 2.08% 1.96% 1.55% 1.94% 1.08%
2025/04/19 11.09% 17.19% 4% 3.07% 5.03% 3.13% 0.88% 1.48% 1.42% 2.07%
2025/04/20 15.29% 13.88% 3.77% 2.16% 5.49% 1.65% 2.01% 1.13% 1.53% 2.62%
2025/04/21 16.8% 6.32% 6.05% 2.8% 7.23% 1.82% 4.38% 1.11% 2.03% 0.62%
2025/04/22 10.87% 10.18% 4.79% 3.04% 2.52% 2.03% 3.24% 2% 3.01% 1.81%
2025/04/23 3.43% 12.67% 2.41% 4.25% 1.32% 3.1% 3.93% 2.04% 3.86% 1.9%
2025/04/24 2.1% 9.86% 1.81% 2.83% 2.52% 4.16% 4.07% 2.12% 3.41% 3.73%
2025/04/25 3.75% 12.57% 2.93% 2.38% 1.71% 1.7% 3.1% 2.06% 4.88% 3.6%
2025/04/26 16.72% 12.89% 5.39% 2.26% 2.49% 1.17% 0.94% 1.88% 3.13% 4.04%
2025/04/27 4.08% 13.49% 1.06% 3.23% 2.64% 1.95% 2.2% 1.08% 2.13% 6.54%
2025/04/28 5.06% 14.54% 2.32% 3.59% 1.89% 1.52% 6% 1.73% 3.8% 6.36%
2025/04/29 15.25% 12.23% 2.87% 2.18% 4.66% 2.61% 2.53% 1.69% 1.63% 4.03%
2025/04/30 13.09% 11.84% 6.18% 5.38% 5.14% 3.82% 3.59% 1.51% 1.46% 1.21%

Copyright © Adthena. All rights reserved.

April saw dynamic shifts in PPC spend share. Kisqali.com surged mid-month, peaking at 16.8% on April 21. Keytruda.com maintained steady growth, reaching 17.19% on April 19. By month’s end, both domains showed strong presence, with Kisqali.com at 13.09% and Keytruda.com at 11.84%.

Market Exposure

Competitor Count for US Pharma & Biotech Oncology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/04/01 353
2025/04/02 326
2025/04/03 351
2025/04/04 410
2025/04/05 424
2025/04/06 410
2025/04/07 411
2025/04/08 415
2025/04/09 398
2025/04/10 394
2025/04/11 391
2025/04/12 388
2025/04/13 392
2025/04/14 393
2025/04/15 386
2025/04/16 399
2025/04/17 417
2025/04/18 403
2025/04/19 398
2025/04/20 396
2025/04/21 380
2025/04/22 384
2025/04/23 370
2025/04/24 361
2025/04/25 330
2025/04/26 332
2025/04/27 327
2025/04/28 315
2025/04/29 297
2025/04/30 303

Copyright © Adthena. All rights reserved.

April began with 353 advertisers, peaking at 424 on the 5th. A gradual decline followed, ending with 303 advertisers on the 30th.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Oncology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
keytruda.com 4.63%
kisqali.com 1.69%
opdivo.com 1.14%
kisqali-hcp.com 0.82%
venclexta.com 0.78%
mmissionpossible.com -1.3%
tnbcfoundation.org -1.32%
letschatcart.com -1.4%
clevelandclinic.org -1.58%
breyanzi.com -1.81%

Copyright © Adthena. All rights reserved.

Keytruda.com surged with a 4.63% click share increase, while breyanzi.com dropped by 1.81%.

Campaign Efficiency

US Pharma & Biotech Oncology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date letschatcart.com breyanzi.com keytruda.com kisqali-hcp.com lilly.com kisqali.com mmissionpossible.com belowthebelt.org cancer.org mayoclinic.org
2025/04/01 7.57% 4.59% 0% 0% 0.91% 0.05% 0.34% 0.87% 2.31% 1.41%
2025/04/02 8.41% 3.62% 0% 0% 0.66% 0.08% 0.32% 1.38% 3.48% 1.46%
2025/04/03 5.75% 5.12% 0% 0% 0.64% 0.03% 3.78% 3.12% 2.6% 2.8%
2025/04/04 4.25% 4.61% 3.18% 1.62% 2.05% 1.49% 2.15% 2.08% 1.55% 5.82%
2025/04/05 9.36% 4.38% 2.83% 1.41% 2.32% 1.44% 3.83% 1.96% 2.48% 1.97%
2025/04/06 6.55% 5.01% 3.17% 1.51% 2.17% 1.56% 4.84% 1.7% 2.13% 1.31%
2025/04/07 2.67% 4.87% 3.65% 2.16% 3.01% 2.7% 2.44% 2.58% 2.31% 2.76%
2025/04/08 4.36% 7% 2.72% 2.83% 2.76% 2.1% 0.09% 3.52% 2.35% 2.55%
2025/04/09 2.75% 4.26% 3.91% 1.91% 3.54% 2.59% 0.1% 2.69% 2.65% 2.03%
2025/04/10 4.51% 8.02% 2.82% 1.9% 1.93% 2.05% 6.19% 1.56% 0.98% 1.45%
2025/04/11 4.79% 6.09% 3.04% 2.08% 2.5% 1.73% 0.27% 0.92% 1.75% 6.71%
2025/04/12 4.93% 7.23% 3.33% 1.75% 2.19% 2.29% 0.11% 2.44% 3.69% 2.3%
2025/04/13 4.83% 7.26% 2.93% 1.67% 1.6% 2.05% 4.64% 1.7% 4.13% 2.67%
2025/04/14 2.03% 6.19% 2.61% 1.65% 2.63% 1.96% 1.75% 3.96% 6.66% 2.73%
2025/04/15 8.69% 9.71% 2.42% 1.65% 3.09% 1.31% 3.38% 1.86% 3.18% 1.71%
2025/04/16 7.98% 9.03% 2.73% 0.75% 1.82% 1.49% 6.03% 3.51% 2.38% 1.11%
2025/04/17 3.92% 6.5% 2.48% 1.38% 2.45% 1.43% 2.37% 1.37% 1.4% 4.69%
2025/04/18 6.32% 3.91% 3.62% 3.19% 3.86% 3.45% 3.7% 0.92% 1.62% 2.07%
2025/04/19 4.23% 6.98% 7.88% 2.68% 3.09% 3.48% 0.06% 2.23% 2.65% 1.72%
2025/04/20 1.96% 3.07% 6.51% 2.98% 3.49% 4.81% 0.1% 1.87% 4.12% 1.97%
2025/04/21 0.31% 3.65% 3.23% 4.96% 4.12% 6.07% 0.12% 0.89% 0.99% 1.67%
2025/04/22 4.62% 4.59% 3.87% 3.93% 2.27% 3.02% 2.31% 0% 1.96% 2.31%
2025/04/23 3.61% 6.8% 5.61% 2.26% 0.96% 1.4% 0.22% 2.33% 1.57% 2.56%
2025/04/24 3.29% 5.6% 3.4% 1.54% 2.05% 0.86% 0.1% 3.31% 3.95% 1.49%
2025/04/25 0.11% 3.88% 5.87% 2.32% 1.88% 1.38% 0.03% 4.46% 4.28% 0.58%
2025/04/26 2.59% 2.13% 6.52% 3.93% 2.57% 3.17% 0.1% 4.43% 7.35% 0.75%
2025/04/27 0.3% 2.06% 4.62% 0.89% 0.95% 0.92% 0.05% 3.58% 6.09% 1.74%
2025/04/28 0.09% 1.48% 7.58% 2.24% 1.7% 1.75% 0.03% 1.58% 8.61% 2.21%
2025/04/29 7% 4.9% 5.4% 2.14% 2.82% 2.37% 0.31% 6.04% 5.6% 0.46%
2025/04/30 9.75% 7.56% 5.84% 5.6% 4.43% 3.97% 3.38% 1.89% 1.09% 0.83%

Copyright © Adthena. All rights reserved.

In April 2025, letschatcart.com saw fluctuating impressions, peaking at 9.75% on the 30th. Breyanzi.com maintained a steady presence, with a high of 9.71% on the 15th. Keytruda.com started slow but gained momentum, ending at 5.84%. Kisqali-hcp.com and lilly.com showed modest growth, while mmissionpossible.com and belowthebelt.org had sporadic spikes. Cancer.org and mayoclinic.org experienced varied trends, with cancer.org peaking at 8.61% on the 28th.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Oncology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    KEYTRUDA® (pembrolizumab) - Official Patient Site https://www.keytruda.com/patient-site

    Find More Information About KEYTRUDA on the Official Patient Site. Learn More Here. Virtual Assistant. Types: Medication Guide, Safety Information, Side Effects, Prescribing Information, Financial Help, Virtual Assistant.

  2. 2
    What is CAR T-Cell Therapy? - Learn About CAR T-Cell Therapy Prescription treatment website

    CAR T-Cell Therapy Helps Your Immune System Fight Against Certain Relapsed Blood Cancers.

  3. 3
    Visit the HCP Website | Car-T for Multiple Myeloma https://www.mmissionpossible.com

    Learn how ongoing research on novel binding domains can impact the future of BCMA Therapy.

  4. 4
    Kisqali (ribociclib) | Critical Drug Prescribing Info https://www.prescriberpoint.com

    A free platform where providers can access support they need from pharmaceutical companies

  5. 5
    What is myeloma - What is Multiple Myeloma https://www.thermofisher.com › multiple › myeloma

    Multiple myeloma is the second most common blood cancer in the United States. Learn more.

Copyright © Adthena. All rights reserved.

In the competitive landscape of oncology PPC ads, Keytruda’s official site emphasizes comprehensive patient support, while CAR T-Cell Therapy highlights immune system empowerment. Mmissionpossible.com focuses on BCMA Therapy advancements, PrescriberPoint offers provider support, and Thermo Fisher educates on multiple myeloma.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

Related reports

US
Pharma & Biotech

US Pharmacology

US
Pharma & Biotech

US Research and Development

US
Pharma & Biotech

US Pulmonology

UK
Pharma & Biotech

UK Pharmacology